Antipsychotic Polypharmacy, Part 2: Why Use 2 Antipsychotics When 1 Is Not Good Enough?

Christoph U. Correll, MD

Published: May 11, 2008

Article Abstract

Last month’s CORNER article examinedthe potential reasons and rationales for andconcerns about the combined use of antipsychotics.This article will review theevidence regarding the efficacy and safetyof antipsychotic polypharmacy in the treatmentof schizophrenia.

Volume: 69

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...